Libya vs Tajikistan: Cause of death, by non-communicable diseases, ages 15-59, female
Libya
60.9%
in 2021
Tajikistan
60.5%
in 2021
Libya rank
95th
Tajikistan rank
96th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Libya
- Tajikistan
How they compare
Libya currently reports 60.9% against 60.5% in Tajikistan, a difference of 0.4%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tajikistan ahead.
Libya ranks 95th and Tajikistan ranks 96th of 185 countries.
Across the 3 decades both report, Libya averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Libya | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.5% | 70.8% | 2.3% | Tajikistan |
| 2010s | 68.3% | 77.7% | 9.4% | Tajikistan |
| 2020s | 62.9% | 57.1% | 5.7% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Libya or Tajikistan?
- Libya, at 60.9% against 60.5% in Tajikistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Libya and Tajikistan?
- 0.4%, with Libya ahead.
- How many years of comparable data are there for Libya and Tajikistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Tajikistan rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Libya ranks 95th and Tajikistan ranks 96th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.